AbbVie Deutschla nd GmbH & Co. KG
- J01 - Antibacterianos para uso sistémico
- XYDALBA powder for solution for infusion 500 mg
- J05 - Antivirales de uso sistémico
- KALETRA film-coated tablet 100 mg+25 mg
- KALETRA oral solution 400 mg/5 ml+100 mg/5 ml
- MAVIRET film-coated tablet 100 mg+40 mg
- NORVIR film-coated tablet 100 mg
- NORVIR powder for oral suspension 100 mg
- VIEKIRAX film-coated tablet 12.5 mg+75 mg+50 mg
- J06 - Sueros inmunes e inmunoglobulinas
- SYNAGIS powder and solvent for solution for injection 100 mg
- SYNAGIS powder and solvent for solution for injection 50 mg
- L01 - Antineoplásicos
- VENCLYXTO film-coated tablet 10 mg
- VENCLYXTO film-coated tablet 100 mg
- VENCLYXTO film-coated tablet 50 mg
- L04 - Inmunosupresores
- HUMIRA PREFILLED PEN solution for injection 40 mg/0.8 ml
- HUMIRA PREFILLED SYRINGE solution for injection 20 mg/0.2 ml
- HUMIRA PREFILLED SYRINGE solution for injection 40 mg/0.8 ml
- RINVOQ prolonged-release tablet 15 mg
- SKYRIZI PREFILLED SYRINGE solution for injection 75 mg/0.83 ml